Member Info for JimiHendrix

I think LTH might have been referring to the II placing when he said it will be oversubscribed.

Yes, I was about to post the same!

The Genedrive POC test is a molecular test, it’s the fact that it’s a molecular test that makes it more accurate. PCR tests are the most commonly known molecular test, and need a lab. So the Genedrive POC is like a next generation PCR, aimed at point of care though rather than high throughput.

Rather than the rubbish antigen tests (LFT etc).

Don’t get me wrong lol, I am not targeting £2 or even saying it will go there, I’m just responding to Jay’s original question asking if anybody thinks it could reach £2. We all know what good sentiment can do to a stock, and Genedrive have a great chance in making a success of POC and AIHL, so let’s see what happens. My short term target is in the region of 40-50.

I’m not saying it’ll be worth £2 in the next 12 months but there’s every chance it could spike to £2 in that time. It touched £3 last May for instance, which was way over valued… but that’s the nature of AIM stocks once sentiment improves.

I think most people had given up on the high throughput test months ago.

Even if all the open offer shares are taken up, including the £10m funds the share price should be about 35p. That will give us a similar mcap as we had before the placing (approx £25m) plus £10m extra cash.

True, though I can also see the possibility of a spike or two, to £2 levels in the next 12 months, not a sustained rise but I do believe we could hit that area. Covid cases are only going to increase over the autumn and winter which will without doubt bring attention to Covid stocks again… particularly those with next generation tests (genedrive).

Placing last year was announced May not July, closer to 18 months than a year.

After the shares are issued (including open offer) the mcap will be more than that... about £25m at 25p, but as you point out they'll have an extra £10m cash, so that alone should push the share price up to about 35p (£35m mcap). Before any upcoming news about AIHL and POC...

Might be - I'm already kicking myself for not buying any yesterday! I'd like a few more under 25p.

Even with the new shares there will only be about 100m shares (assuming open offer taken up in full) which is still a really low amount in issue. Compared to many other companies who have billions.

Yes £2 is very possible over the next 12 months if AIHL gets taken up in Europe and we get some decent orders for the POC test. That will be around £175-200m mcap depending on whether open offer taken up.

The market makers worked to move it to the placing price from 40, they opened it at the placing price immediately when the news came out. They’ll let it shoot up again in a flash soon, once they have their shares.

Demand in America for a fast (antigen like) PCR (accurate) test…the POC test fits the bill exactly…

https://t.co/UpUMpMWCmf

The very definition of "optimistic" is confidence.... "Hopeful and confident about the future"

Possibly. But the 40% discount will have been enough incentive imo - they know they'll be able to make a decent profit selling the shares they've bought at 25p with the news flow expected over the next few weeks and months.

The median average salary of CEOs in AIM listed companies is £325k. They're all massively over paying themselves.

Jay, I'm very confident you'll get your money back. It's not like the company is falling to pieces, they're on the cusp of launching 2 very impressive products and are very well funded. It's easy to let emotions get the better of you, I just keep thinking if I wasn't already invested I would look at the situation and not only feel sorry for holders with high averages but also that this is probably a very good time to buy.

If you're thinking of buying more, my advice considering you have a massive holding already would be to wait just incase it does briefly drop another 10%-20%. I don't think it will, but if you miss out on averaging down further you've still a great chance in getting your money back over the next month imo with your current average price. Will be interesting to see the price action this week and next.

Yes and also crucially the drop doesn’t take into consideration the cash the company is actually getting from the fundraise. The full fundraise should boost the mcap by £10m taking the price up to about 34p as things stand. Or a bit higher still if the open offer isn’t taken up.

Then we should get some decent AIHL and POC news to take it up further. Things will begin to become exciting here again.

I think there’s foul play going on behind the scenes in all aspects of business. Though when company is getting desperate they shouldn’t push their luck, it would be excellent for sentiment if they said they’ve managed to reduce monthly cash burn buy sourcing more competitive suppliers or anything to reduce the costs… unless they’re absolutely vital to the running.

Sally, I know how tempting it can be to jump into another stock when the stock you’re in crashes and when sentiment seems so low. I used to do that all the time, for years. And almost every single time the original company ended up flying back up, and almost always I lost more money in the shiny new stock that seemed to be a no brainer in comparison to the seemingly hopeless and down stock that crashed. So I’m definitely not selling genedrive to buy another stock lol. I’ve also never seen sentiment so low in this company, and I know if I wasn’t already in it I’d be seeing this as pretty good buy at the moment… which is indeed why I’ve been buying more. The placing was my big worry and now that’s done, I see mainly upside …and from this level it could be a pretty big rise. I keep reminding myself also that the Genedrive deice is their main product, the high throughput Covid test was a surprise opportunity which in fairness they developed quickly. The mistake was expecting the FDA to continue approving large numbers of tests, the reality was after the initial mass EUA approvals in the first few months of the pandemic they slowed right down. Of course though, I can’t understand why they didn’t just reduce the cost and sell it cheaply to Divoc. I keep thinking about this, there hasn’t been a good explanation. We also haven’t been updated how many tests BC have actually sold, and whether they’re still trying. Presumably they haven’t given up as the test is still all over their site. Who knows!!

But at this price i think it will soon start to look attractive again.

It’s a bit more than just a room in Manchester university, it’s in the Incubator building…

“ The Manchester Incubator Building is a state-of-the-art biotechnology research and development centre combining the latest in laboratory facilities with an excellent infrastructure. This combination of an exceptional building resource with a commercially and academically supportive company offers a unique package for biotech start-ups, R&D satellites from pharmaceutical companies and service based companies.”

https://techmanchester.co.uk/hubs/5y8qy0l

But still, I agree their salaries are way too high… and I’m not sure where 400k a month is going. Seems to be a similar situation with most AIM companies though.